New peer-reviewed study on telehealth-delivered allergy drops (SLIT)

Wanted to share a study that just came out in Frontiers in Allergy (June 2026) looking at outcomes for people using telehealth-delivered sublingual immunotherapy — basically allergy drops managed remotely instead of through in-office visits.

A few things it looked at:

• Symptom improvement over the treatment period
• Adherence rates for at-home dosing vs. what's typically seen with in-clinic allergy shots
• Patient-reported outcomes on quality of life

Worth noting upfront: like a lot of real-world telehealth studies, it relies partly on self-reported data and the sample size isn't huge, so it's not the final word — but it's a solid addition to the growing body of research on whether remote allergy care can hold up against traditional in-person treatment.

If you want to dig into the methodology or full results, here's the paper

Curious if anyone here has done SLIT drops vs. traditional shots — how has adherence been for you? Did doing it at home make it easier to stick with, or harder to stay consistent without the accountability of an office visit?